SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TITAN PHARMACEUTICAL (TTP) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (77)8/8/1999 2:16:00 PM
From: Biomaven  Read Replies (1) | Respond to of 362
 
Repricings are pretty much a thing of the past now, thanks to SEC pressure on FASB. Repricings after Dec 15, 1998 will almost certainly produce (the dreaded) variable accounting - this means a real earnings charge (of the amount of the spread) when they are finally exercised.

Peter



To: scaram(o)uche who wrote (77)8/18/1999 7:45:00 PM
From: RWReeves  Respond to of 362
 
They need not have bothered. Another few weeks and it may get above water for the original price.
RWR


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News